Skip to content

Clinical trials

Seizures trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Seizures Country / region: Canada Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20042
20052
20061
20082
20094
20101
20114
20121
20132
20141
20163
20175
20185
20193
20205
20211
20221
20233
20244
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated10
Unknown status4
Not yet recruiting4
Active, not recruiting3
Recruiting3
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto4
Longboard Pharmaceuticals3
Sumitomo Pharma America, Inc.3
University of Calgary3
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.3
Eisai Inc.2
GlaxoSmithKline2
Novartis Pharmaceuticals2
Roxane Laboratories2
Sunnybrook Health Sciences Centre2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Seizures57
Epilepsy34
Epilepsies, Myoclonic9
Drug Resistant Epilepsy6
Tuberous Sclerosis5
Brain Diseases4
Heart Arrest4
Lennox Gastaut Syndrome4
Epilepsies, Partial3
Ischemic Stroke3

Trials

Showing 76 to 57 of 57. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.